Terry Box

2.8k total citations
32 papers, 492 citations indexed

About

Terry Box is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Terry Box has authored 32 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 15 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Terry Box's work include Hepatitis C virus research (26 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (10 papers). Terry Box is often cited by papers focused on Hepatitis C virus research (26 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (10 papers). Terry Box collaborates with scholars based in United States, Germany and Puerto Rico. Terry Box's co-authors include Bergein F. Overholt, Louis Y. Korman, Norman Sussman, Christopher H. Remien, Frederick R. Adler, William R. Hutson, Richard Manch, Karla Thornton, Robin D. Kim and John B. Sorensen and has published in prestigious journals such as Gastroenterology, Hepatology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Terry Box

30 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry Box United States	10	269	218	144	113	92	32	492
Nina Weiler Germany	12	288 1.1×	267 1.2×	146 1.0×	123 1.1×	38 0.4×	42	578
Edward W. Holt United States	12	203 0.8×	217 1.0×	155 1.1×	92 0.8×	83 0.9×	29	441
Ken Flora United States	9	145 0.5×	129 0.6×	175 1.2×	98 0.9×	96 1.0×	11	433
John P. Norvell United States	12	266 1.0×	253 1.2×	90 0.6×	30 0.3×	28 0.3×	21	444
Juliane Liese Germany	15	226 0.8×	203 0.9×	257 1.8×	97 0.9×	124 1.3×	48	722
Arun Jesudian United States	14	511 1.9×	433 2.0×	166 1.2×	29 0.3×	29 0.3×	70	683
Elaine Cristina de Ataíde Brazil	13	239 0.9×	175 0.8×	194 1.3×	35 0.3×	22 0.2×	60	460
Sylvie Janny France	10	250 0.9×	240 1.1×	308 2.1×	170 1.5×	129 1.4×	14	568
Stéphanie Faure France	15	315 1.2×	436 2.0×	162 1.1×	108 1.0×	18 0.2×	39	744
Valentina Rosa Bertuzzo Italy	16	410 1.5×	278 1.3×	402 2.8×	93 0.8×	38 0.4×	31	680

Countries citing papers authored by Terry Box

Since Specialization

Citations

This map shows the geographic impact of Terry Box's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Box with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Box more than expected).

Fields of papers citing papers by Terry Box

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Box. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Box. The network helps show where Terry Box may publish in the future.

Co-authorship network of co-authors of Terry Box

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Box. A scholar is included among the top collaborators of Terry Box based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Box. Terry Box is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serper, Marina, Terry Box, Christian B. Ramers, et al.. (2022). A simplified algorithm for managing hepatitis C infection by leveraging telemedicine. Gastroenterology & Hepatology Open Access. 13(1). 12–20. 1 indexed citations

Hassanein, Tarek, Dean Tai, Chenghai Liu, et al.. (2022). Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 9 indexed citations

Thornton, Karla, Paulina Deming, Richard Manch, et al.. (2016). Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment. Hepatology International. 10(4). 624–631. 8 indexed citations

Poordad, F., Michael Bennett, Thomas Sepe, et al.. (2016). Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study. Journal of Hepatology. 64(2). S767–S768. 18 indexed citations

Owens, Christopher M., Bradley Brasher, Xiaowen Peng, et al.. (2016). Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239. Antimicrobial Agents and Chemotherapy. 60(10). 6207–6215. 3 indexed citations

Kohli, Anita, Karla Thornton, James D. Reynolds, et al.. (2016). Primary Care Physicians Utilizing the Echo Model Equally Effective as Subspecialists Treating HCV using Direct-Acting Antivirals-Only Regimens: Results of the Echo Model. Journal of Hepatology. 64(2). S818–S819. 2 indexed citations

Kowdley, Kris V., Daniel Nelson, Jacob Lalezari, et al.. (2015). P0829 : On-treatment HCVRNA as a predictor of sustained virologic response in HCV genotype 3 infected patients treated with daclatasvir and sofosbuvir: analysis of phase 3 ALLY-3 study. Journal of Hepatology. 62. S648–S648. 2 indexed citations

Kowdley, Kris V., David R. Nelson, Jacob Lalezari, et al.. (2015). Tu1013 On-Treatment HCV RNA As a Predictor of Sustained Virologie Response in HCV Genotype 3 - Infected Patients Treated With Daclatasvir and Sofosbuvir: Analysis of Phase 3 Ally-3 Study. Gastroenterology. 148(4). S–1084. 1 indexed citations

Lawitz, Eric, William O’Riordan, Armen Asatryan, et al.. (2015). Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection. Antimicrobial Agents and Chemotherapy. 60(3). 1546–1555. 40 indexed citations

10.

Flamm, Steven L., Edward Gane, Jean‐François Dufour, et al.. (2014). Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials. Hepatology. 60. 4 indexed citations

11.

Mitruka, Kiren, Karla Thornton, Richard Manch, et al.. (2014). Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model--Arizona and Utah, 2012-2014.. UNM’s Digital Repository (University of New Mexico). 63(18). 393–8. 48 indexed citations

12.

Bernstein, David, Jacob Lalezari, Yan Luo, et al.. (2014). Su1061 Pearl-IV: a 12-Week Regimen of ABT-450/r/ABT-267 and ABT-333, With or Without Ribavirin Achieves Svr12 Rates≥90% in Treatment-Naïve Adults Infected With Hepatitis C Virus Genotype 1A. Gastroenterology. 146(5). S–977. 1 indexed citations

13.

Selzman, Craig H., Terry Box, William R. Hutson, et al.. (2013). Minimally invasive aortic valve replacement with orthotopic liver transplantation: report of a case. Surgery Today. 44(3). 546–549. 7 indexed citations

14.

Lalezari, Jacob, Terry Box, William O’Riordan, et al.. (2013). Idx184 in Combination with Pegylated Interferon-α2A and Ribavirin for 2 Weeks in Treatment-Naive Patients with Chronic Hepatitis C. Antiviral Therapy. 18(6). 755–764. 9 indexed citations

15.

Remien, Christopher H., et al.. (2012). Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: Early discrimination between survival and death. Hepatology. 56(2). 727–734. 55 indexed citations

16.

Schwartz, Jason J., Lisa M. Pappas, Gabriela Vargas, et al.. (2012). Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience#*. Liver Transplantation. 18(4). 423–433. 49 indexed citations

17.

Byrne, Janice L. B., et al.. (2010). Recurrent liver failure in a 25-year-old female. Liver Transplantation. 16(9). 1049–1053. 19 indexed citations

18.

Gaglio, Paul J., M. Rodríguez‐Torres, Robert Herring, et al.. (2004). Racial Differences in Response Rates to Consensus Interferon in HCV Infected Patients Naive to Previous Therapy. Journal of Clinical Gastroenterology. 38(7). 599–604. 21 indexed citations

19.

Korman, Louis Y., et al.. (2003). Perforation During Colonoscopy in Endoscopic Ambulatory Surgical Centers. Gastrointestinal Endoscopy. 58(4). 554–557. 131 indexed citations

20.

Ghalib, Reem, Risë Stribling, Terry Box, et al.. (2003). Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2b plus ribavirin. Preliminary analysis. Gastroenterology. 124(4). A694–A694. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact